Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Abruptio Placenta
NCT05840471Completed
- Sponsor
- Hawler Medical University
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in abruptio placentae (2 arms), sponsored by Hawler Medical University. Primary endpoints: Hemostasis, Gestational age and 1 more. Started Jan 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
abruptio placentae
Beyond the preview
Go deeper on NCT05840471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05840471.